K Kawa

2.3k total citations
51 papers, 1.6k citations indexed

About

K Kawa is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, K Kawa has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 20 papers in Immunology and 19 papers in Oncology. Recurrent topics in K Kawa's work include Hematopoietic Stem Cell Transplantation (22 papers), Immune Cell Function and Interaction (11 papers) and Acute Lymphoblastic Leukemia research (11 papers). K Kawa is often cited by papers focused on Hematopoietic Stem Cell Transplantation (22 papers), Immune Cell Function and Interaction (11 papers) and Acute Lymphoblastic Leukemia research (11 papers). K Kawa collaborates with scholars based in Japan, United States and Greece. K Kawa's co-authors include Ritsuro Suzuki, Junji Suzumiya, Kazuo Oshimi, Shôji Nakamura, Masaki Inoue, Masayoshi Yasui, Naoki Sakata, Takayuki Okamura, Hisashi Sakamaki and Hiroki Sugimori and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

K Kawa

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Kawa Japan 21 715 677 646 506 221 51 1.6k
Atsushi Kikuta Japan 21 596 0.8× 654 1.0× 337 0.5× 256 0.5× 228 1.0× 118 1.5k
Gwynn D. Long United States 23 759 1.1× 1.2k 1.7× 542 0.8× 487 1.0× 189 0.9× 83 2.0k
Keisei Kawa‐Ha Japan 19 651 0.9× 705 1.0× 796 1.2× 476 0.9× 186 0.8× 49 1.7k
Daniele Laszlò Italy 20 709 1.0× 597 0.9× 223 0.3× 649 1.3× 188 0.9× 67 1.6k
A Grañena Spain 22 426 0.6× 846 1.2× 329 0.5× 359 0.7× 217 1.0× 86 1.6k
Esteban Abella United States 17 512 0.7× 551 0.8× 233 0.4× 225 0.4× 202 0.9× 56 1.3k
Carmen Canals Spain 24 1.1k 1.5× 1.1k 1.6× 579 0.9× 1.2k 2.3× 288 1.3× 51 2.3k
Keiko Yumura‐Yagi Japan 18 332 0.5× 605 0.9× 343 0.5× 243 0.5× 383 1.7× 49 1.2k
Noga Shem‐Tov Israel 23 584 0.8× 1.0k 1.5× 291 0.5× 241 0.5× 409 1.9× 85 1.7k
Laurent Sutton France 26 1.1k 1.5× 1.3k 1.9× 546 0.8× 753 1.5× 327 1.5× 61 2.7k

Countries citing papers authored by K Kawa

Since Specialization
Citations

This map shows the geographic impact of K Kawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Kawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Kawa more than expected).

Fields of papers citing papers by K Kawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Kawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Kawa. The network helps show where K Kawa may publish in the future.

Co-authorship network of co-authors of K Kawa

This figure shows the co-authorship network connecting the top 25 collaborators of K Kawa. A scholar is included among the top collaborators of K Kawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Kawa. K Kawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kudo, Kazuko, Hideki Muramatsu, Nao Yoshida, et al.. (2015). Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia. Bone Marrow Transplantation. 50(10). 1312–1315. 12 indexed citations
2.
Kato, Motohiro, Kenji Matsumoto, Ritsuro Suzuki, et al.. (2013). Salvage allogeneic hematopoietic SCT for primary graft failure in children. Bone Marrow Transplantation. 48(9). 1173–1178. 17 indexed citations
3.
Kurosawa, Saiko, Kimikazu Yakushijin, Takuhiro Yamaguchi, et al.. (2013). Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia. Bone Marrow Transplantation. 48(9). 1198–1204. 20 indexed citations
4.
Imahashi, Nobuhiko, Ritsuro Suzuki, Takahiro Fukuda, et al.. (2012). Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR. Bone Marrow Transplantation. 48(1). 56–62. 12 indexed citations
5.
Kato, Motohiro, Yasuo Horikoshi, Yasuhiro Okamoto, et al.. (2012). Second allogeneic hematopoietic SCT for relapsed ALL in children. Bone Marrow Transplantation. 47(10). 1307–1311. 29 indexed citations
6.
7.
Ishiyama, Ken, Akiyoshi Takami, Yoshinobu Kanda, et al.. (2011). Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis. Leukemia. 26(3). 461–464. 13 indexed citations
8.
Inamoto, Yoshihiro, Koichi Miyamura, Shiki Okamoto, et al.. (2010). Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan marrow donor program. Bone Marrow Transplantation. 46(9). 1192–1202. 3 indexed citations
9.
Mizuta, Shuichi, Keitaro Matsuo, Fumiharu Yagasaki, et al.. (2010). Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia. Leukemia. 25(1). 41–47. 74 indexed citations
10.
Suzuki, Ritsuro, Junji Suzumiya, Motoko Yamaguchi, et al.. (2009). Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Annals of Oncology. 21(5). 1032–1040. 185 indexed citations
11.
Kawa, K, Mamoru Uemura, Seiji Kato, et al.. (2007). Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels. Bone Marrow Transplantation. 40(3). 251–259. 28 indexed citations
12.
Yumura‐Yagi, Keiko, Masaki Inoue, Naoki Sakata, et al.. (2005). Unrelated donor bone marrow transplantation for 100 pediatric patients: a single institute's experience. Bone Marrow Transplantation. 36(4). 307–313. 6 indexed citations
13.
14.
Imashuku, Shinsaku, Kiminori Terui, T Matsuyama, et al.. (2003). Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan. Bone Marrow Transplantation. 31(12). 1127–1135. 14 indexed citations
15.
Inoue, Masaki, Akihiro Yoneda, Masanori Nishikawa, et al.. (2003). Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation. Bone Marrow Transplantation. 32(1). 103–106. 43 indexed citations
16.
Ikeda, Hitoshi, Tomoko Iehara, Yumi Tsuchida, et al.. (2002). Experience with International Neuroblastoma Staging System and Pathology Classification. British Journal of Cancer. 86(7). 1110–1116. 48 indexed citations
17.
Yoshioka, Akira, K Kawa, Hiromichi Ishizashi, et al.. (2002). Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation. Bone Marrow Transplantation. 29(9). 789–794. 42 indexed citations
18.
19.
Imashuku, Shinsaku, Shigeyoshi Hibi, Shinjiro Todo, et al.. (1999). Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplantation. 23(6). 569–572. 57 indexed citations
20.
Imamura, N, Yoichiro Kusunoki, Oda K, et al.. (1989). [Aggressive natural killer cell leukemia/lymphoma--possible existence of a new clinical entity originating from the third lineage of lymphoid cells].. PubMed. 30(2). 193–201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsushi Kikuta Breakdown of academic impact, for papers by Gwynn D. Long Breakdown of academic impact, for papers by Keisei Kawa‐Ha Breakdown of academic impact, for papers by Daniele Laszlò Breakdown of academic impact, for papers by A Grañena Breakdown of academic impact, for papers by Esteban Abella Breakdown of academic impact, for papers by Carmen Canals Breakdown of academic impact, for papers by Keiko Yumura‐Yagi Breakdown of academic impact, for papers by Noga Shem‐Tov Breakdown of academic impact, for papers by Laurent Sutton
Rankless by CCL
2026